Acute vertebrobasilar occlusion: treatment with high-dose intraarterial urokinase.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10063865.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to describe our successful experience with high-dose intraarterial urokinase therapy in treating acute, life-threatening vertebrobasilar occlusion. We successfully treated five patients with acute vertebrobasilar occlusion who presented up to 24 hr after the onset of symptoms. Higher doses of urokinase than are commonly reported in the literature were used in this series at a rapid infusion rate with a "pulse-spray" technique. The result was prompt thrombolysis and good clinical outcome.
Medical subject headings
- Plasminogen Activators
- Urokinase-Type Plasminogen Activator
- Vertebrobasilar Insufficiency